These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 8671975

  • 41. Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy.
    Stangou M, Alexopoulos E, Papagianni A, Pantzaki A, Bantis C, Dovas S, Economidou D, Leontsini M, Memmos D.
    Nephrology (Carlton); 2009 Sep; 14(6):613-20. PubMed ID: 19143943
    [Abstract] [Full Text] [Related]

  • 42. The levels of circulating and urinary monocyte chemoattractant protein-1 are associated with chronic renal injury in obese men.
    Fu CP, Lee IT, Sheu WH, Lee WJ, Liang KW, Lee WL, Lin SY.
    Clin Chim Acta; 2012 Oct 09; 413(19-20):1647-51. PubMed ID: 22609259
    [Abstract] [Full Text] [Related]

  • 43. Serum level of soluble fibrinogen-like protein 2 in renal allograft recipients with acute rejection: a preliminary study.
    Zhao Z, Yang C, Tang Q, Zhao T, Jia Y, Ma Z, Rong R, Xu M, Zhu T.
    Transplant Proc; 2012 Dec 09; 44(10):2982-5. PubMed ID: 23195010
    [Abstract] [Full Text] [Related]

  • 44. Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Levels and Its Association with Renal Allograft Rejection.
    Raza A, Firasat S, Khaliq S, Khan AR, Mahmood S, Aziz T, Mubarak M, Naqvi SA, Rizvi SA, Abid A.
    Immunol Invest; 2017 Apr 09; 46(3):251-262. PubMed ID: 27960564
    [Abstract] [Full Text] [Related]

  • 45. MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy.
    Grandaliano G, Gesualdo L, Bartoli F, Ranieri E, Monno R, Leggio A, Paradies G, Caldarulo E, Infante B, Schena FP.
    Kidney Int; 2000 Jul 09; 58(1):182-92. PubMed ID: 10886563
    [Abstract] [Full Text] [Related]

  • 46. Monocyte chemoattractant protein-1 and RANTES are chemotactic for graft infiltrating lymphocytes during acute lung allograft rejection.
    Sekine Y, Yasufuku K, Heidler KM, Cummings OW, Van Rooijen N, Fujisawa T, Brown J, Wilkes DS.
    Am J Respir Cell Mol Biol; 2000 Dec 09; 23(6):719-26. PubMed ID: 11104723
    [Abstract] [Full Text] [Related]

  • 47. Noninvasive detection of acute renal allograft rejection by measurement of soluble Tim-3 in urine.
    Chen D, Peng W, Jiang H, Yang H, Wu J, Wang H, Chen J.
    Mol Med Rep; 2017 Jul 09; 16(1):915-921. PubMed ID: 28586044
    [Abstract] [Full Text] [Related]

  • 48. Association of MCP-1 and CCR2 polymorphisms with the risk of late acute rejection after renal transplantation in Korean patients.
    Kang SW, Park SJ, Kim YW, Kim YH, Sohn HS, Yoon YC, Joo H, Jeong KH, Lee SH, Lee TW, Ihm CG.
    Int J Immunogenet; 2008 Feb 09; 35(1):25-31. PubMed ID: 18186797
    [Abstract] [Full Text] [Related]

  • 49. Prediction of chronic allograft damage index of renal allografts using serum level of plasminogen activator inhibitor-1.
    Chang HR, Yang SF, Lian JD, Lin CC, Wen MC, Chen YT, Jan YJ, Hsieh YS.
    Clin Transplant; 2009 Feb 09; 23(2):206-12. PubMed ID: 19220364
    [Abstract] [Full Text] [Related]

  • 50. Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patents with hemolytic uremic syndrome.
    van Setten PA, van Hinsbergh VW, van den Heuvel LP, Preyers F, Dijkman HB, Assmann KJ, van der Velden TJ, Monnens LA.
    Pediatr Res; 1998 Jun 09; 43(6):759-67. PubMed ID: 9621985
    [Abstract] [Full Text] [Related]

  • 51. Elevated urinary CCL2: Cr at 6 months is associated with renal allograft interstitial fibrosis and inflammation at 24 months.
    Ho J, Wiebe C, Gibson IW, Hombach-Klonisch S, Gao A, Rigatto C, Karpinski M, Storsley L, Nickerson PW, Rush DN.
    Transplantation; 2014 Jul 15; 98(1):39-46. PubMed ID: 24646773
    [Abstract] [Full Text] [Related]

  • 52. Localization of C-X-C and C-C chemokines to renal tubular epithelial cells in human kidney transplants is not confined to acute cellular rejection.
    Sibbring JS, Sharma A, McDicken IW, Sells RA, Christmas SE.
    Transpl Immunol; 1998 Dec 15; 6(4):203-8. PubMed ID: 10342733
    [Abstract] [Full Text] [Related]

  • 53. Elevated urinary sVCAM-1, IL6, sIL6R and TNFR1 concentrations indicate acute kidney transplant rejection in the first 2 weeks after transplantation.
    Reinhold SW, Straub RH, Krüger B, Kaess B, Bergler T, Weingart C, Banas MC, Krämer BK, Banas B.
    Cytokine; 2012 Mar 15; 57(3):379-88. PubMed ID: 22209080
    [Abstract] [Full Text] [Related]

  • 54. Urine macrophage migration inhibitory factor concentrations as a diagnostic tool in human renal allograft rejection.
    Brown FG, Nikolic-Paterson DJ, Chadban SJ, Dowling J, Jose M, Metz CN, Bucala R, Atkins RC.
    Transplantation; 2001 Jun 27; 71(12):1777-83. PubMed ID: 11455258
    [Abstract] [Full Text] [Related]

  • 55. Elevated urinary CXCL10-to-creatinine ratio is associated with subclinical and clinical rejection in pediatric renal transplantation.
    Blydt-Hansen TD, Gibson IW, Gao A, Dufault B, Ho J.
    Transplantation; 2015 Apr 27; 99(4):797-804. PubMed ID: 25222013
    [Abstract] [Full Text] [Related]

  • 56. Application of antibody array technology in the analysis of urinary cytokine profiles in patients with chronic kidney disease.
    Liu BC, Zhang L, Lv LL, Wang YL, Liu DG, Zhang XL.
    Am J Nephrol; 2006 Apr 27; 26(5):483-90. PubMed ID: 17095863
    [Abstract] [Full Text] [Related]

  • 57. Osteopontin level correlates with acute cellular renal allograft rejection.
    Wang J, Tang Q, Qiu Y, Xu M, Rong R, Zhu T.
    J Surg Res; 2013 Jun 01; 182(1):161-5. PubMed ID: 22947699
    [Abstract] [Full Text] [Related]

  • 58. Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular diseases.
    Chen YM, Lin SL, Chiang WC, Wu KD, Tsai TJ.
    Kidney Int; 2006 Apr 01; 69(8):1410-5. PubMed ID: 16541021
    [Abstract] [Full Text] [Related]

  • 59. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy.
    Morii T, Fujita H, Narita T, Shimotomai T, Fujishima H, Yoshioka N, Imai H, Kakei M, Ito S.
    J Diabetes Complications; 2003 Apr 01; 17(1):11-5. PubMed ID: 12505750
    [Abstract] [Full Text] [Related]

  • 60. Urinary C‑X‑C motif chemokine 13 is a noninvasive biomarker of antibody‑mediated renal allograft rejection.
    Chen D, Zhang J, Peng W, Weng C, Chen J.
    Mol Med Rep; 2018 Aug 01; 18(2):2399-2406. PubMed ID: 29956754
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.